
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia
Susan H. Fox, Matthew Swan, Hyder A. Jinnah, et al.
Movement Disorders Clinical Practice (2021) Vol. 8, Iss. 5, pp. 743-749
Open Access | Times Cited: 8
Susan H. Fox, Matthew Swan, Hyder A. Jinnah, et al.
Movement Disorders Clinical Practice (2021) Vol. 8, Iss. 5, pp. 743-749
Open Access | Times Cited: 8
Showing 8 citing articles:
Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today
Daniel P. Radin, Arnold S. Lippa, Sabhya Rana, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 248, pp. 173967-173967
Closed Access
Daniel P. Radin, Arnold S. Lippa, Sabhya Rana, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 248, pp. 173967-173967
Closed Access
An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm
Gamze Kilic‐Berkmen, Hodam Kim, Dongdong Chen, et al.
Movement Disorders (2024) Vol. 39, Iss. 4, pp. 738-745
Closed Access | Times Cited: 2
Gamze Kilic‐Berkmen, Hodam Kim, Dongdong Chen, et al.
Movement Disorders (2024) Vol. 39, Iss. 4, pp. 738-745
Closed Access | Times Cited: 2
An overview of the pharmacotherapeutics for dystonia: advances over the past decade
O. Abu-hadid, Joohi Jimenez‐Shahed
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 17, pp. 1927-1940
Closed Access | Times Cited: 6
O. Abu-hadid, Joohi Jimenez‐Shahed
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 17, pp. 1927-1940
Closed Access | Times Cited: 6
Advances in targeting neurotransmitter systems in dystonia
Dora Steel, Kimberley M. Reid, Antonio Pisani, et al.
International review of neurobiology (2023), pp. 217-258
Closed Access | Times Cited: 3
Dora Steel, Kimberley M. Reid, Antonio Pisani, et al.
International review of neurobiology (2023), pp. 217-258
Closed Access | Times Cited: 3
A digital patient-centered outcome tool for cervical dystonia
Sarah Pirio Richardson, Brian D. Berman, Janet Hieshetter, et al.
Dystonia (2024) Vol. 3
Open Access
Sarah Pirio Richardson, Brian D. Berman, Janet Hieshetter, et al.
Dystonia (2024) Vol. 3
Open Access
Efficacy and Safety of Sodium Oxybate in Isolated Focal Laryngeal Dystonia: A Phase IIb Double‐Blind Placebo‐Controlled Cross‐Over Randomized Clinical Trial
Kristina Simonyan, Lena C. O’Flynn, Azadeh Hamzehei Sichani, et al.
Annals of Neurology (2024)
Closed Access
Kristina Simonyan, Lena C. O’Flynn, Azadeh Hamzehei Sichani, et al.
Annals of Neurology (2024)
Closed Access
Perampanel: Medical Alternative for Essential Tremor?
Lola Díaz-Feliz, Cici Feliz-Feliz, Javier del Val, et al.
Clinical Neuropharmacology (2023)
Closed Access | Times Cited: 1
Lola Díaz-Feliz, Cici Feliz-Feliz, Javier del Val, et al.
Clinical Neuropharmacology (2023)
Closed Access | Times Cited: 1
¿Existe evidencia científica para el empleo de perampanel en el dolor neuropático?
A Alcántara-Montero, SL Vasconcelos
Revista de Neurología (2022) Vol. 75, Iss. 01, pp. 21-21
Open Access
A Alcántara-Montero, SL Vasconcelos
Revista de Neurología (2022) Vol. 75, Iss. 01, pp. 21-21
Open Access